Cargando…
Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells
Although runt-related transcription factor 1 (RUNX1) and its associating core binding factor-β (CBFB) play pivotal roles in leukemogenesis, and inhibition of RUNX1 has now been widely recognized as a novel strategy for anti-leukemic therapies, it has been elusive how leukemic cells could acquire the...
Autores principales: | Morita, Ken, Noura, Mina, Tokushige, Chieko, Maeda, Shintaro, Kiyose, Hiroki, Kashiwazaki, Gengo, Taniguchi, Junichi, Bando, Toshikazu, Yoshida, Kenichi, Ozaki, Toshifumi, Matsuo, Hidemasa, Ogawa, Seishi, Liu, Pu Paul, Nakahata, Tatsutoshi, Sugiyama, Hiroshi, Adachi, Souichi, Kamikubo, Yasuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709397/ https://www.ncbi.nlm.nih.gov/pubmed/29192243 http://dx.doi.org/10.1038/s41598-017-16799-z |
Ejemplares similares
-
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells
por: Mitsuda, Yoshihide, et al.
Publicado: (2018) -
RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
por: Kubota, Hirohito, et al.
Publicado: (2021) -
Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells
por: Noura, Mina, et al.
Publicado: (2020) -
RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
por: Masuda, Tatsuya, et al.
Publicado: (2021) -
RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
por: Mikami, Masamitsu, et al.
Publicado: (2022)